Variant report

Variant	nsv613692
Chromosome Location	chr9:16963863-17070633
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:17057789-17058149	HepG2	liver:	n/a	n/a
2	BATF	chr9:17057808-17058032	GM12878	blood:	n/a	n/a
3	BHLHE40	chr9:17057793-17058031	HepG2	liver:	n/a	n/a
4	CBX3	chr9:16996867-16997187	HCT-116	colon:	n/a	n/a
5	CBX3	chr9:16996907-16997260	HCT-116	colon:	n/a	n/a
6	CEBPB	chr9:17031555-17031833	HepG2	liver:	n/a	chr9:17031696-17031707
7	CEBPB	chr9:16985908-16986453	IMR90	lung:	n/a	n/a
8	CEBPB	chr9:16996969-16997259	HepG2	liver:	n/a	n/a
9	CEBPB	chr9:17021419-17021740	A549	lung:	n/a	n/a
10	CEBPB	chr9:17021416-17021683	HepG2	liver:	n/a	n/a
11	CEBPB	chr9:17021424-17021724	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr9:17009388-17009729	IMR90	lung:	n/a	chr9:17009575-17009584 chr9:17009575-17009584
13	CEBPB	chr9:16996959-16997300	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr9:17003595-17004419	IMR90	lung:	n/a	n/a
15	CEBPB	chr9:16996962-16997280	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr9:17033518-17033953	A549	lung:	n/a	n/a
17	CEBPB	chr9:17033642-17033959	HepG2	liver:	n/a	n/a
18	CEBPB	chr9:16996894-16997318	ECC-1	luminal epithelium:	n/a	n/a
19	CEBPB	chr9:17009423-17009667	A549	lung:	n/a	chr9:17009575-17009584 chr9:17009575-17009584
20	CEBPB	chr9:17021238-17021833	IMR90	lung:	n/a	n/a
21	CEBPB	chr9:16964093-16964576	IMR90	lung:	n/a	chr9:16964182-16964194
22	CEBPB	chr9:16996936-16997307	IMR90	lung:	n/a	n/a
23	CEBPB	chr9:17021301-17021774	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr9:16996967-16997310	A549	lung:	n/a	n/a
25	CEBPB	chr9:16996899-16997347	A549	lung:	n/a	n/a
26	CEBPB	chr9:16996932-16997321	ECC-1	luminal epithelium:	n/a	n/a
27	CEBPB	chr9:16996916-16997232	MCF-7	breast:	n/a	n/a
28	CEBPB	chr9:17057772-17058066	HepG2	liver:	n/a	n/a
29	CEBPB	chr9:16996909-16997268	A549	lung:	n/a	n/a
30	CEBPB	chr9:16982707-16982907	A549	lung:	n/a	n/a
31	CHD2	chr9:16983682-16983875	HepG2	liver:	n/a	n/a
32	CHD2	chr9:16983667-16983917	H1-hESC	embryonic stem cell:	n/a	n/a
33	CTCF	chr9:17063522-17063869	ECC-1	luminal epithelium:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
34	CTCF	chr9:17063640-17063790	GM12875	blood:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
35	CTCF	chr9:17063720-17063870	A549	lung:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
36	CTCF	chr9:17063611-17063868	Gliobla	brain:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
37	CTCF	chr9:17021820-17021970	AG10803	skin:	n/a	n/a
38	CTCF	chr9:17054080-17054230	RPTEC	kidney:	n/a	n/a
39	CTCF	chr9:16987020-16987170	HPF	lung:	n/a	n/a
40	CTCF	chr9:17063640-17063790	GM12868	blood:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
41	CTCF	chr9:16978201-16978256	MCF-7	breast:	n/a	n/a
42	CTCF	chr9:16985180-16985330	HPF	lung:	n/a	n/a
43	CTCF	chr9:17063656-17063818	MCF-7	breast:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
44	CTCF	chr9:16974522-16974568	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr9:17063640-17063790	K562	blood:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
46	CTCF	chr9:17063620-17063770	GM12874	blood:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
47	CTCF	chr9:17063540-17063690	GM12869	blood:	n/a	n/a
48	CTCF	chr9:17063660-17063810	GM12864	blood:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746
49	CTCF	chr9:17063080-17063230	HCFaa	heart:	n/a	n/a
50	CTCF	chr9:17063660-17063802	H1-hESC	embryonic stem cell:	n/a	chr9:17063734-17063742 chr9:17063729-17063747 chr9:17063731-17063752 chr9:17063730-17063746

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16964111-16964161	SAEC	small airway:	n/a
2	chr9:16964111-16964161	HRE	kidney:	n/a
3	chr9:16964111-16964161	Caco-2	colon:	n/a
4	chr9:16964111-16964161	HCF	heart:	n/a
5	chr9:16964111-16964161	PFSK-1	brain:	n/a
6	chr9:16964111-16964161	Jurkat	blood:	n/a
7	chr9:16964111-16964161	IMR90	lung:	fetal
8	chr9:16964111-16964161	HRPEpiC	eye:	n/a
9	chr9:16964111-16964161	Hepatocyte	liver:	n/a
10	chr9:16964111-16964161	GM12891	blood:	n/a
11	chr9:16964111-16964161	U87	brain:	n/a
12	chr9:16964111-16964161	GM12892	blood:	n/a
13	chr9:16964111-16964161	ProgFib	skin:	n/a
14	chr9:16964111-16964161	A549	lung:	n/a
15	chr9:16964111-16964161	ECC-1	luminal epithelium:	n/a
16	chr9:16964111-16964161	NH-A	brain:	n/a
17	chr9:16964111-16964161	HMEC	breast:	n/a
18	chr9:16964111-16964161	AoSMC	blood vessel:	n/a
19	chr9:16964111-16964161	HCM	heart:	n/a
20	chr9:16964111-16964161	BJ	skin:	n/a
21	chr9:16964111-16964161	NHBE	bronchial:	n/a
22	chr9:16964111-16964161	AG09319	gingival:	n/a
23	chr9:16964111-16964161	Hela-S3	cervix:	n/a
24	chr9:16964111-16964161	AG04450	lung:	fetal
25	chr9:16964111-16964161	BE2_C	brain:	n/a
26	chr9:16964111-16964161	HepG2	liver:	n/a
27	chr9:16964111-16964161	CMK	blood:	n/a
28	chr9:16964111-16964161	K562	blood:	n/a
29	chr9:16964111-16964161	HEEpiC	esophagus:	n/a
30	chr9:16964111-16964161	HRCEpiC	kidney:	n/a
31	chr9:16964111-16964161	NHDF-neo	bronchial:	n/a
32	chr9:16964111-16964161	GM06990	blood:	n/a
33	chr9:16964111-16964161	SK-N-MC	brain:	n/a
34	chr9:16964111-16964161	MCF-7	breast:	n/a
35	chr9:16964111-16964161	HIPEpiC	eye:	n/a
36	chr9:16964111-16964161	GM12878	blood:	n/a
37	chr9:16964111-16964161	HNPCEpiC	eye:	n/a
38	chr9:16964111-16964161	LNCaP	prostate:	n/a
39	chr9:16964111-16964161	ovcar-3	ovarian:	n/a
40	chr9:16964111-16964161	MCF10A-Er-Src	breast:	n/a
41	chr9:16964111-16964161	T-47D	breast:	n/a
42	chr9:16964111-16964161	HAEpiC	amniotic membrane:	n/a
43	chr9:16964111-16964161	HL-60	blood:	n/a
44	chr9:16964111-16964161	SK-N-SH_RA	brain:	n/a
45	chr9:16964111-16964161	HCPEpiC	choroid plexus:	n/a
46	chr9:16964111-16964161	PrEC	prostate:	n/a
47	chr9:16964111-16964161	HPAEpiC	pulmonary alveolar:	n/a
48	chr9:16964111-16964161	HEK293	kidney:	embryo
49	chr9:16964111-16964161	HCT-116	colon:	n/a
50	chr9:16964111-16964161	NB4	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:17063303..17064146-chr9:17462547..17463504,3	MCF-7	breast:
2	chr9:17004932..17007249-chr9:17011274..17013104,2	MCF-7	breast:
3	chr9:17004932..17007249-chr9:17011274..17013104,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNTLN-1	chr9:17048917-17049039	ENSG00000237153.1
2	lnc-CNTLN-4	chr9:17053899-17054200	NONHSAT130298

Variant related genes	Relation type
RN7SL720P	TF binding region
ENSG00000237153	TF binding region
RN7SL720P	CpG island
ENSG00000237153	CpG island

Extended variants
information (count: 3416 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:3416 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11791614	chr9:16963863-16963864	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs143611504	chr9:16963889-16963890	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs11787736	chr9:16963900-16963901	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs552632051	chr9:16963938-16963939	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs528960189	chr9:16963946-16963947	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs527687450	chr9:16963949-16963950	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs546844342	chr9:16963952-16963953	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs568277359	chr9:16963963-16963964	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs535622333	chr9:16964001-16964002	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
10	rs372742014	chr9:16964025-16964026	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
11	rs550822957	chr9:16964059-16964060	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
12	rs568969187	chr9:16964066-16964067	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
13	rs371822931	chr9:16964075-16964076	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
14	rs137994261	chr9:16964078-16964079	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
15	rs557890042	chr9:16964092-16964093	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
16	rs142570317	chr9:16964111-16964112	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
17	rs570892876	chr9:16964130-16964131	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
18	rs533569516	chr9:16964179-16964180	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
19	rs535576768	chr9:16964196-16964197	Enhancers Flanking Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
20	rs556011272	chr9:16964211-16964212	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
21	rs528666156	chr9:16964252-16964253	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
22	rs574281412	chr9:16964253-16964254	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
23	rs544400827	chr9:16964258-16964259	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
24	rs74610489	chr9:16964312-16964313	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
25	rs577828061	chr9:16964320-16964321	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
26	rs550923363	chr9:16964400-16964401	Enhancers Active TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
27	rs146011856	chr9:16964416-16964417	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs560401470	chr9:16964443-16964444	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs114165295	chr9:16964479-16964480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs67344794	chr9:16964498-16964499	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs561993286	chr9:16964521-16964522	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs139863336	chr9:16964555-16964556	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs376263702	chr9:16964572-16964573	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs7868980	chr9:16964597-16964598	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs539844409	chr9:16964598-16964599	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs551461508	chr9:16964600-16964601	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs566482569	chr9:16964629-16964630	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs377346279	chr9:16964691-16964692	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs533760602	chr9:16964701-16964702	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs7869202	chr9:16964709-16964710	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs532602747	chr9:16964716-16964717	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs373202530	chr9:16964764-16964765	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs574267840	chr9:16964782-16964783	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs538111591	chr9:16964787-16964788	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs556444430	chr9:16964789-16964790	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs71513282	chr9:16964799-16964800	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs139047039	chr9:16964804-16964805	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs71513283	chr9:16964814-16964815	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs58818603	chr9:16964826-16964827	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs67435368	chr9:16964830-16964831	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21611746	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16960400-16964000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr9:16963600-16964200	Enhancers	NHLF	lung
3	chr9:16963600-16965000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr9:16963600-16965200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr9:16963600-16965200	Enhancers	NHDF-Ad	bronchial
6	chr9:16963800-16964200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr9:16963800-16964200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
8	chr9:16963800-16964200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr9:16963800-16964400	Enhancers	NH-A	brain
10	chr9:16963800-16965200	Enhancers	Osteobl	bone
11	chr9:16964000-16964200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr9:16964000-16964200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr9:16964000-16964400	ZNF genes & repeats	Aorta	Aorta
14	chr9:16964200-16964400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr9:16964200-16964800	Enhancers	Muscle Satellite Cultured Cells	--
16	chr9:16965200-16969200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr9:16965200-16970600	Weak transcription	NHDF-Ad	bronchial
18	chr9:16969200-16970000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr9:16970000-16970400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr9:16970400-16971400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr9:16970600-16971200	Enhancers	NHDF-Ad	bronchial
22	chr9:16982800-16983200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr9:16982800-16983400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr9:16983000-16983800	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr9:16983000-16984400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr9:16983200-16983800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr9:16983400-16984200	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr9:16983400-16984600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr9:16983600-16983800	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr9:16983800-16984000	Enhancers	iPS-20b Cell Line	embryonic stem cell
31	chr9:16983800-16984400	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr9:16983800-16984600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr9:16983800-16985800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
34	chr9:16984000-16984400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr9:16984000-16985800	Weak transcription	NHLF	lung
36	chr9:16984200-16987200	Weak transcription	HUES48 Cell Line	embryonic stem cell
37	chr9:16984400-16985000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr9:16984400-16986000	Weak transcription	HUES64 Cell Line	embryonic stem cell
39	chr9:16984400-16988000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr9:16984600-16984800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr9:16984600-16984800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr9:16984600-16985000	Enhancers	Fetal Stomach	stomach
43	chr9:16984600-16985400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr9:16984600-16985800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr9:16984600-16986000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
46	chr9:16984800-16985000	Enhancers	iPS-20b Cell Line	embryonic stem cell
47	chr9:16984800-16986000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr9:16984800-16986000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr9:16984800-16986000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr9:16985000-16985200	Enhancers	Aorta	Aorta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links